Grape King Bio Stock Fundamentals
| 1707 Stock | TWD 155.00 1.00 0.65% |
Grape King Bio fundamentals help investors to digest information that contributes to Grape King's financial success or failures. It also enables traders to predict the movement of Grape Stock. The fundamental analysis module provides a way to measure Grape King's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Grape King stock.
Grape |
Grape King Bio Company Current Valuation Analysis
Grape King's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Grape King Current Valuation | 20.28 B |
Most of Grape King's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Grape King Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Grape King Bio has a Current Valuation of 20.28 B. This is 41.22% higher than that of the Personal Products sector and 172.82% higher than that of the Consumer Staples industry. The current valuation for all Taiwan stocks is 22.01% lower than that of the firm.
Grape King Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grape King's current stock value. Our valuation model uses many indicators to compare Grape King value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grape King competition to find correlations between indicators driving Grape King's intrinsic value. More Info.Grape King Bio is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about 0.56 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grape King Bio is roughly 1.79 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Grape King's earnings, one of the primary drivers of an investment's value.Grape Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Grape King's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Grape King could also be used in its relative valuation, which is a method of valuing Grape King by comparing valuation metrics of similar companies.Grape King is currently under evaluation in current valuation category among its peers.
Grape Fundamentals
| Return On Equity | 0.21 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 20.28 B | |||
| Shares Outstanding | 148.14 M | |||
| Shares Owned By Insiders | 20.08 % | |||
| Shares Owned By Institutions | 21.48 % | |||
| Price To Earning | 21.08 X | |||
| Price To Book | 2.57 X | |||
| Price To Sales | 2.26 X | |||
| Revenue | 9.8 B | |||
| Gross Profit | 7.86 B | |||
| EBITDA | 2.85 B | |||
| Net Income | 1.3 B | |||
| Cash And Equivalents | 2.03 B | |||
| Cash Per Share | 14.95 X | |||
| Total Debt | 87.38 M | |||
| Debt To Equity | 19.80 % | |||
| Current Ratio | 0.90 X | |||
| Book Value Per Share | 61.47 X | |||
| Cash Flow From Operations | 2.54 B | |||
| Earnings Per Share | 9.57 X | |||
| Target Price | 173.5 | |||
| Number Of Employees | 24 | |||
| Beta | 0.44 | |||
| Market Capitalization | 25.55 B | |||
| Total Asset | 14.06 B | |||
| Retained Earnings | 2.4 B | |||
| Working Capital | 890 M | |||
| Current Asset | 2.86 B | |||
| Current Liabilities | 1.97 B | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.06 % | |||
| Net Asset | 14.06 B | |||
| Last Dividend Paid | 6.1 |
About Grape King Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Grape King Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grape King using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grape King Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Grape King Bio Ltd primarily produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan. The company was founded in 1969 and is headquartered in Taoyuan, Taiwan. GRAPE KING operates under Drug Manufacturers - Specialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Grape Stock Analysis
When running Grape King's price analysis, check to measure Grape King's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grape King is operating at the current time. Most of Grape King's value examination focuses on studying past and present price action to predict the probability of Grape King's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grape King's price. Additionally, you may evaluate how the addition of Grape King to your portfolios can decrease your overall portfolio volatility.